New Strategy to Disarm Acute Myeloid Leukemia (AML) Resistance
|
Along with his research team, Moores Member Robert Signer, PhD has identified why AML resists proteasome-inhibitor drugs. Blocking the backup survival pathway of AML makes treatment far more effective. Learn More»
|
New Precision Medicine Therapeutics in Oncology (PMTO) Program |
|
|
In the video linked below, Moores Member Scott Lippman, MD explains the vision of the PMTO program, key features of its curriculum, and how it will advance precision oncology. The PMTO program lies at the intersection of medicine, genomics, and cancer therapy, and applications are now open.
Apply Now» | View Video» | Learn More»
|
Precision Reprogramming: How AI Can Trick Cancer Cells
|
Researchers at UC San Diego have developed an AI-powered approach for reprogramming colon cancer stem cells to self-destruct, which can reduce recurrence and mortality risk by up to 50 percent. This approach utilizes human organoids, rather than animal testing, to provide safer, more precise cancer therapies. Learn More»
|
|
|
Empowering Breast Cancer Patients After Treatment
|
UC San Diego Health’s Breast Cancer Survivorship Program provides its patients with long-term physical, emotional, and holistic support after treatment, such as personalized care plans, exercise guidance, counseling, and nutrition resources, empowering them to regain confidence and thrive. Learn More»
|
|
|
Sanford Compassionate Communication Academy Fellowship Program |
This 5-month hybrid program trains UC San Diego physicians, nurses, APPs, and medical educators to become leaders in compassionate communication. Fellows leave the program as department-based experts who can champion a culture of empathy. Learn More» | Apply Now»
|
| Media Interview Training with Davey Smith, MD (KPBS)
|
Join this training session on Friday, February 27, 2025 from 9:00 a.m. to 10:00 a.m. in Skaggs Pharmaceutical Sciences Building Classroom 1170 to learn how to work with journalists and conduct interviews. Space is limited.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
View featured limited submission, federal, and non-federal grant and funding opportunities. |
High Impact Specialized Innovation Programs—RC2
|
The NIH National Center for Advancing Translational Sciences RC2 mechanism supports high-impact projects to address gaps in and barriers to clinical and translational science. Learn more»
|
Application Deadline: October 21, 2025
Submission Instructions: Email all relevant Word documents and PDFs to papatwardhan@health.ucsd.edu and ryohe@health.ucsd.edu
|
American Cancer Society (ACS) Institutional Research Grant 2026 |
Moores Member Michael Bouvet, MD, Member of the Local Committee of the ACS Institutional Research Grant (ACS-IRG-24-1317140-51-IRG), is pleased to announce the availability of seed money to stimulate cancer research projects of high merit among junior investigators at UC San Diego.
|
Application Deadline: November 10, 2025
Apply Now»
|
Hanna and Mark Gleiberman Head & Neck Cancer Center 2025 Research Pilot Project Grant Opportunity
|
This grant will fund research projects to improve curative therapy and the quality of care for head and neck cancer patients and their families. Project proposals may target any aspect of head and neck cancer care or head and neck and/or voice disease etiology, diagnosis, and therapy.
|
Application Deadline: November 14, 2025
Apply Now»
|
|
|
| Macrophage-engaging IgG4 antibody triggers cytotoxicity against integrin αvβ3+ cancers |
Molecular Cancer Therapeutics
|
Mark Onaitis, MD (Cancer Biology and Signaling), David Cheresh, PhD (Solid Tumor Therapeutics), and Hiromi Wettersten, DVM, PhD (Solid Tumor Therapeutics)
|
|
|
| Financial navigation for people newly diagnosed with cancer: Primary outcomes from the cancer financial experience randomized trial |
Mateo Banegas, PhD, MPH, MS (Cancer Control)
|
|
|
| Metabolomic biomarkers of rest-activity rhythms in older women: Results from the women's health initiative (WHI) study |
Andrea LaCroix, PhD (Cancer Control)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
|
|
No newly activated clinical trails.
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE)
|
PAP Rally & Cervical Cancer Collaborative |
COE partnered with Owens Clinic and UC San Diego Health at the PAP rally to provide patients with health screenings and mobile mammography. View Video»
COE also hosted the third 2025 session of the Cervical Cancer Quality Improvement Learning Collaborative with over 17 partners to address barriers to care and strategies to improve patient navigation.
|
The Science Of Substance Use and the Body |
The latest episode of The Science Of . . features Dr. Alexander Wallace, a postdoctoral fellow at UCSD's psychiatry department. Dr. Wallace discusses the impact of substance use on neurodevelopment and aerobic fitness in young adults. Listen here»
|
|
|
|
